NAA50 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.267800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.650000E-01
Normal-vs-Stage2
7.455400E-01
Normal-vs-Stage3
6.093600E-01
Normal-vs-Stage4
2.842600E-01
Stage1-vs-Stage2
6.123400E-01
Stage1-vs-Stage3
6.052600E-01
Stage1-vs-Stage4
1.537000E-01
Stage2-vs-Stage3
3.720400E-01
Stage2-vs-Stage4
1.411230E-01
Stage3-vs-Stage4
1.442620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.380000E-01
Normal-vs-AfricanAmerican
5.920200E-01
Normal-vs-Asian
6.191800E-01
Caucasian-vs-AfricanAmerican
4.246800E-01
Caucasian-vs-Asian
2.870200E-01
AfricanAmerican-vs-Asian
1.782440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.293200E-01
Normal-vs-Female
8.092000E-01
Male-vs-Female
9.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.053600E-01
Normal-vs-Age(41-60Yrs)
5.078600E-01
Normal-vs-Age(61-80Yrs)
9.917800E-01
Normal-vs-Age(81-100Yrs)
9.299400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.162400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.786000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.329200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.755900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.596200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.525200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.557400E-01
Normal-vs-Daily Drinker
9.964400E-01
Normal-vs-Weekly Drinker
8.279400E-01
Normal-vs-Occasional Drinker
5.203800E-01
Normal-vs-Social Drinker
8.497200E-01
Non Drinker-vs-Daily Drinker
7.310600E-01
Non Drinker-vs-Weekly Drinker
9.665600E-01
Non Drinker-vs-Occasional Drinker
9.408100E-02
Non Drinker-vs-Social Drinker
4.649600E-01
Daily Drinker-vs-Weekly Drinker
7.573200E-01
Daily Drinker-vs-Occasional Drinker
1.696160E-01
Daily Drinker-vs-Social Drinker
7.362000E-01
Weekly Drinker-vs-Occasional Drinker
1.042970E-01
Weekly Drinker-vs-Social Drinker
5.219600E-01
Occasional Drinker-vs-Social Drinker
3.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.800400E-01
Normal-vs-Grade 2
3.617500E-02
Normal-vs-Grade 3
5.476200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.177800E-03
Grade 1-vs-Grade 3
2.139600E-03
Grade 1-vs-Grade 4
3.800400E-01
Grade 2-vs-Grade 3
2.661000E-01
Grade 2-vs-Grade 4
3.617500E-02
Grade 3-vs-Grade 4
5.476200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.000600E-01
Normal-vs-NonDiabetic
9.662000E-01
Diabetic-vs-NonDiabetic
7.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.205200E-01
Normal-vs-NoPancreatitis
9.080600E-01
Pancreatitis-vs-NoPancreatitis
7.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.543600E-01
Normal-vs-N1
7.176800E-01
N0-vs-N1
3.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.546000E-01
Normal-vs-TP53-NonMutant
8.477800E-01
TP53-Mutant-vs-TP53-NonMutant
1.161380E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
